LLY vs PFE

Lilly (Eli) (LLY) and Pfizer (PFE) compared side by side. Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $171.2B for Pfizer, about 6.6 times the size. On trailing earnings, PFE is cheaper at 39.5x versus 42.7x for LLY.

Head to head

MetricLLYPFE
Market cap$1.1T$171.2B
P/E (TTM)42.7x39.5x
Forward P/E27.0x10.4x
Revenue (TTM)$79.7B$63.7B
Revenue growth47.7%2.6%
Gross margin83.4%74.7%
Operating margin54.2%27.9%
Free cash flow$13.6B$11.0B
Dividend yield0.54%5.73%
1-year return+56.1%+30.3%
5-year return (annual)+40.5%-1.9%
Max drawdown-68%-69%
FI Handbook gradeBC+

Highlighted: the stronger figure on metrics where higher or lower is clearly better.

Growth of $10,000 (5 years, price only)

$20.0K
$40.0K
20222023202420252026
LLYPFE

LLY vs PFE FAQ

Which is bigger, LLY or PFE?

Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $171.2B for Pfizer, about 6.6 times the size.

Is LLY or PFE cheaper?

On trailing earnings, PFE is cheaper at 39.5x versus 42.7x for LLY. A lower P/E can reflect slower expected growth, so compare growth and margins too.

Which stock performed better over the past year, LLY or PFE?

LLY returned +56.1% over the past year including dividends, versus +30.3% for PFE, through October 23, 2026.

Which pays a higher dividend, LLY or PFE?

PFE yields 5.73% versus 0.54% for LLY.

Full pages: Lilly (Eli) · Pfizer